Arcutis Biotherapeutics Set for Key Investor Conferences

Author: Evelyn Baker Updated: 08-19-2025 04:21 PM

Arcutis Biotherapeutics Announces Upcoming Investor Participation

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), known for its innovative contributions in immuno-dermatology, has exciting news regarding its participation in several forthcoming investor conferences. This initiative represents the company's ongoing commitment to fostering relationships with investors and sharing important updates regarding their progress and future endeavors.

Details of Upcoming Conferences

Arcutis management will engage in discussions at three key investor conferences where they will share insights into their advancements and future goals. Here’s what to expect:

Citi’s 2025 Biopharma Back to School Conference

This conference is scheduled for September 2-3, 2025. The highlighted event will feature a fireside chat on September 3rd at 9:45 AM EDT. This session provides investors with a unique opportunity to engage with Arcutis leaders as they delve into recent developments in their pipeline and strategic outlook.

Morgan Stanley’s 23rd Annual Global Healthcare Conference

Taking place from September 8-10, 2025, this conference will include a crucial fireside chat on September 9 at 2:35 PM EDT. Attendees will gain insight into how Arcutis is addressing significant challenges in dermatological care, further emphasizing its dedication to patient well-being and therapeutic innovation.

HC Wainwright 27th Annual Global Investment Conference

Also occurring from September 8-10, 2025, Arcutis will participate in this event, specifically on September 10 at 10:30 AM EDT. This conference is another prime opportunity for investors to hear directly from Arcutis about the growth of its product offerings and the impacts these have on patient populations.

Accessing the Webcasts

For those who cannot attend, Arcutis will provide webcasts of these conferences accessible via the Events section on the company’s official website. Replays of these sessions will be available for 180 days post-conference, ensuring that interested parties can access this valuable information at their convenience.

About Arcutis

Arcutis Biotherapeutics, Inc., a commercial-stage medical dermatology entity, is dedicated to innovation aimed at improving the lives of individuals with immune-mediated dermatological diseases. With an expanding portfolio of advanced therapies, Arcutis addresses critical needs in the treatment of major inflammatory skin conditions. Leveraging a unique dermatological development platform, the company continues to focus on creating differentiated therapies supported by scientifically validated targets, enhancing its pipeline for inflammatory dermatological conditions.

Frequently Asked Questions

What upcoming conferences will Arcutis participate in?

Arcutis will participate in Citi's 2025 Biopharma Conference, Morgan Stanley's Global Healthcare Conference, and HC Wainwright's Global Investment Conference.

When will the fireside chats take place?

The fireside chats are scheduled for September 3rd, September 9th, and September 10th at various times.

How can I access the webcasts of these conferences?

The webcasts can be accessed in the Events section of Arcutis's official website and will also be available for replay for 180 days following the conferences.

What is the focus of Arcutis Biotherapeutics?

Arcutis focuses on developing innovative treatments for immune-mediated dermatological diseases, offering advanced solutions for patients facing major inflammatory skin conditions.

Who should I contact for more information?

For media inquiries, you can contact Amanda Sheldon, Head of Corporate Communications. For investor inquiries, reach out to Brian Schoelkopf.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.